News Teva's CEO Vigodman steps down Firm searches for new leader, chairman takes over on interim basis.
Views & Analysis Making the case for pharmaceutical IP management IP management can protect pharma companies’ investments and future R&D.
News EU drug regulators concerned about Brexit impact European regulators concerned over impact of EMA move.
News Novartis less exposed to US pricing pressure, says Jimenez Europe and Asia account for a large share of company's income.
Views & Analysis Recent trends in ANDA litigation Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
